Showing results (41-50 of 210) with videos related to

Sort By:
Pageof 21
Frontiers in Cellular and Infection Microbiology|June 16, 2025
Oral pathologic conditions and impaired cytokine response in patients with previous cerebral abscess or cervical necrotizing soft tissue infectionFrederik Viktor Bang Jespersen, Signe Undall-Behrend Hansen, Sisse Rye Ostrowski, et al.
Transplantation and Cellular Therapy|July 12, 2021
Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell TransplantationLars Klingen Gjærde, Anne Louise Tølbøll Sørensen, Jakob Hjorth von Stemann, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2021
The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in DenmarkEva Leinøe, Nanna Brøns, Andreas Ørslev Rasmussen, et al.
BMC Infectious Diseases|July 5, 2019
Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trialCamilla Heldbjerg Drabe, Søren Schwartz Sørensen, Allan Rasmussen, et al.
Frontiers in Immunology|November 12, 2020
Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic ReviewOmid Rezahosseini, Dina Leth Møller, Andreas Dehlbæk Knudsen, et al.
Frontiers in Cellular and Infection Microbiology|May 27, 2021
Stimulated Immune Response by TruCulture® Whole Blood Assay in Patients With European Lyme Neuroborreliosis: A Prospective Cohort StudyMathilde Ørbæk, Rosa Maja Møhring Gynthersen, Helene Mens, et al.
Transplantation and Cellular Therapy|November 14, 2022
Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell TransplantationLars Klingen Gjærde, Sisse Rye Ostrowski, Frederikke Schierbeck, et al.
Scientific Reports|December 15, 2021
Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profilesJakob Hjorth von Stemann, Lars Klingen Gjærde, Eva Kannik Haastrup, et al.
European Journal of Haematology|December 14, 2020
Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantationLars Klingen Gjaerde, Sisse Rye Ostrowski, Lia Minculescu, et al.
Transplantation and Cellular Therapy|February 20, 2025
Plasma Nucleosome Levels and Risk of Acute Graft-Versus-Host Disease After Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Cohort StudySune Holm Hansen, Sisse Rye Ostrowski, Niels Smedegaard Andersen, et al.
Pageof 21